Basic symptom-modifying delayed-action drugs in therapy of osteoporosis
Glucosamine sulfate, or hydrochloride, and chondroitin sulfate are natural components of cartilaginous intercellular substance. In osteoarthrosis (OA), they exert a pronounced symptom-modifying effect and, when used long, they can also inhibit the X-ray progression of OA. The combination drugs that...
Saved in:
| Main Authors: | Vladimir Vasil'evich Badokin, Vladimir Vasilievich Badokin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2011-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/372 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knee osteoarthrosis: Clinical presentation, diagnosis, treatment
by: Vladimir Vasilyevich Badokin
Published: (2013-10-01) -
Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis
by: A. P. Rebrov, et al.
Published: (2016-06-01) -
Artra is a model of combination symptom-modifying therapy for osteoarthrosis and intervertebral osteochondrosis
by: V V Badokin
Published: (2012-06-01) -
Chondroitin sulfate: the mechanisms of action, its efficacy and safety in the therapy of osteoarthrosis
by: S G Anikin, et al.
Published: (2012-09-01) -
Showiness or efficiency: what to choose?
by: D.G. Rekalov, et al.
Published: (2013-08-01)